2023


  1. Lohmann B, Kuba K, Götze H, Mehnert-Theuerkauf A, Heyne S, Esser P (2023). Partnership, sexuality, and fertility-related communication: findings from a register-based study among long-term hematological cancer survivors. Supportive Care in Cancer, 31(1), 26.
     
  2. Göbel P, Kuba K, Götze H, Mehnert-Theuerkauf A, Spitzer C, Hartung T, Esser P (2023). Interconnectivity of fear of progression and generalized anxiety - Network analysis among a sample of hematological cancer survivors. Support Care Cancer, 31(4), 238.
     
  3. Springer F, Friedrich M, Kuba K, Ernst J, Glaesmer H, Platzbecker U, Vucinic V, Heyne S, Mehnert-Theuerkauf A, Esser P (2023). New progress in an old debate? Applying the DSM-5 criteria to assess traumatic events and stressor-related disorders in cancer survivors. Psychooncology, 32(10), 1616-1624.
     
  4. Springer F, Kuba K, Ernst J, Friedrich M, Glaesmer H, Platzbecker U, Vucinic V, Heyne S, Mehnert-Theuerkauf A, Esser P (2023). Symptoms of posttraumatic stress disorder and adjustment disorder in hematological cancer patients with different treatment regimes. Acta Oncol, 62(9), 1110-1117.
     


    5. 2020


  5. Baumann E, Kuba K, Götze H, Mehnert-Theuerkauf A, Esser P (2020). Initial validation of the German version of the Attentional Function Index in a sample of haematological cancer survivors. Eur J Cancer Care, 29(4), e13226.
     
  6. Esser P, Mehnert-Theuerkauf A, Friedrich M, Johansen C, Brähler E, Faller H, Härter M, Koch U, Schulz H, Wegscheider K, Weis J, Kuba K, Hinz A, Hartung T (2020). Risk and associated factors of depression and anxiety in men with prostate cancer: Results from a German multicenter study. Psychooncology, 29, 1604-1612.
     


    7. 2019


  7. Kuba K, Esser P, Mehnert A, Hinz A, Johansen C, Lordick F, Götze H (2019). Risk for depression and anxiety in long-term survivors of hematologic cancer. Health Psychol, 38, 187-195.
     
  8. Kuba K, Weißflog G, Götze H, Garcia-Torres F, Mehnert A, Esser P (2019). The relationship between acceptance, fatigue, and subjective cognitive impairment in hematologic cancer survivors. Int J Clin Health Psychol, 19, 97-106.
     
  9. Esser P, Kuba K, Ernst J, Mehnert-Theuerkauf A (2019). Trauma- and stressor-related disorders among hematological cancer patients with and without stem cell transplantation: protocol of an interview-based study according to updated diagnostic criteria. BMC Cancer, 19(1), 870.
     
  10. Esser P, Kuba K (2019). Zentrale psychosoziale Herausforderungen bei Krebsüberlebenden. FORUM, 34, 181-184.
     
  11. Esser P, Götze H, Mehnert-Theuerkauf A, Knoop H, Kuba K (2019). Fear of progression and its role in the relationship of cancer-related fatigue with physical functioning and global quality of life - A register-based study among hematological cancer survivors. J Psychosom Res, 127, 109844.
     


    12. 2018


  12. Esser P, Kuba K, Mehnert A, Johansen C, Hinz A, Lordick F, Götze H (2018). Quality of life in survivors of hematological malignancies stratified by cancer type, time since diagnosis and stem cell transplantation. Eur J Haematol, 101, 340-348.
     


    13. 2017


  13. Kuba K, Weissflog G (2017). Akzeptanz- und Commitmenttherapie bei chronischen körperlichen Erkrankungen. Psychother Psychosom Med Psychol, 67(12), 525-536.
     
  14. Kuba K, Esser P, Mehnert A, Johansen C, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander A, Kröger N, Götze H, Scherwath A (2017). Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany. Bone Marrow Transplant, 52(12), 1651-1657.
     
  15. Esser P, Kuba K, Götze H, Mehnert A (2017). Long-term effects and psychological adjustment: study protocol of a large register-based study on quality of life among survivors of hematological malignancies. BMC Cancer, 17, 482.
     
  16. Esser P, Kuba K, Scherwath A, Johansen C, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander AR, Kröger N, Götze H, Mehnert A (2017). Stability and Priority of Symptoms and Symptom Clusters Among Allogeneic HSCT Patients Within a 5-Year Longitudinal Study. J Pain Symptom Manage, 54(4), 493-500.
     
  17. Kuba K, Esser P, Scherwath A, Schirmer L, Schulz-Kindermann F, Dinkel A, Balck F, Koch U, Kröger N, Götze H, Mehnert A (2017). Cancer-and-treatment-specific distress and its impact on posttraumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Psycho-Oncology, 26(8), 1164-1171.
     
  18. Esser P, Kuba K, Mehnert A, Schwinn A, Schirmer L, Schulz-Kindermann F, Kruse M, Koch U, Zander AR, Kröger N, Schilling G, Götze H, Scherwath A (2017). Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT. Bone Marrow Transplant, 52(5), 753-758.
     
  19. Esser P, Kuba K, Scherwath A, Schirmer L, Schulz-Kindermann F, Dinkel A, Balck F, Koch U, Kröger N, Götze H, Mehnert A (2017). Posttraumatic stress disorder symptomatology in the course of allogeneic HSCT: a prospective study. J Cancer Surviv, 11(2), 203-210.
     
  20. Kuba K, Scheibe S (2017). Let it be and keep on going! Acceptance and daily occupational well-being in relation to negative work events. J Occup Health Psychol, 22(1), 59-70.
     


    21. 2016


  21. Scheibe S, Spieler I, Kuba K (2016). An Older-Age Advantage? Emotion Regulation and Emotional Experience After a Day of Work. Work Aging Retire, 2, 307-320.
     


    22. 2015


  22. Götze H, Kuba K, Esser P, Richter D, Geue K, Brähler E, Köhler N (2015). Psychische und soziale Probleme im Verlauf einer hämatologischen Krebserkrankung. Journal Onkologie, 7, 465-470.